1 / 7

Pneumonia Vaccine Market Size, Share, Growth, Trends, Forecast 2022-2030

Stay up-to-date with latest Insights of Pneumonia Vaccine market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth.<br><br>Get More Info@ https://www.alliedmarketresearch.com/pneumonia-vaccine-market <br>

robertjacksonresearch
Download Presentation

Pneumonia Vaccine Market Size, Share, Growth, Trends, Forecast 2022-2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. What is Pneumonia Vaccine? • Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, virus, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Pneumonia results in inflammation in the air sacs (known as alveoli) of the lungs, which results in filling the alveoli with fluid (pus cells), thus causing breathing problems. Pneumococcal disease is common in young children, but older adults are at greatest risk of serious pneumococcal infections and even death. Pneumonia vaccines are primarily administered to children less than 2-years old and adults aged 65 years and older. This vaccine helps individuals provide immunization against 13 types of pneumococcal bacteria that causes infection in the lungs.

  2. Pneumonia VaccineMarket: Global Major Players • Glaxosmithkline plc., LG Chem Ltd., Merck & Co., Inc., Panacea Biotec Limited, Pfizer Inc., Pnuvax Incorporated, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited), SK Bioscience and Walvax Biotechnology Co., Ltd.

  3. Pneumonia Vaccine Market Segmentation: • by Vaccine Type: Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine • by Product Type: Prevnar 13, Synflorix, Pneumovax 23 • by Sector: Public, Private • by Distribution Channel: Distribution Partner Companies, Non-governmental Organizations (NGO), Government Authorities

  4. Pneumonia Vaccine Market: Regional Outlook • The market is evaluated based on its regional penetration, explaining the performance of the market in each regional market covering regions such as North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) • Get Sample PDF Here>>> https://www.alliedmarketresearch.com/request-sample/2730

  5. About Us: • Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises. • Visit Our Website@ https://www.alliedmarketresearch.com

  6. Contact Us: • David Correa • 5933 NE Win Sivers Drive • #205, Portland, OR 97220 • United States • USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 • UK: +44-845-528-1300 • Hong Kong: +852-301-84916 • India (Pune): +91-20-66346060

More Related